» Articles » PMID: 30759766

The Impact of Low-FODMAPs, Gluten-Free, and Ketogenic Diets on Gut Microbiota Modulation in Pathological Conditions

Overview
Journal Nutrients
Date 2019 Feb 15
PMID 30759766
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota performs several essential protective, structural, and metabolic functions for host health. The maintenance of a beneficial microbiota requires a homeostatic equilibrium within microbial communities, and between the microorganisms and the host. The gut microbiota composition may be affected by external factors, among them diet habits may be considered most important. In some pathological conditions such as irritable bowel syndrome (IBS), celiac disease (CD), or neurological disorders (ND), specific dietary regimens as low-fermentable, oligo-, di-, mono-saccharides and polyols (FODMAPs), ketogenic (KD), and gluten-free (GFD) diets are considered therapeutic. These kinds of diets are characterized by a reduction or exclusion of a specific nutrient from the entire dietary pattern. Despite these alimentary regimens showing beneficial effects on disease symptoms, they can affect microbiota composition, especially if they are protracted for a long time. To date, only a few studies have reported the effects of these diets on gut microbiota. In this review, we discuss the effects of low-FODMAPs, KD, and GFD on gut microbiota modulation in pathological conditions, advancing the possibility of depicting a balanced diet and developing personalized dietary intervention protocols.

Citing Articles

From microbes to medicine: harnessing the power of the microbiome in esophageal cancer.

Liu X, Li B, Liang L, Han J, Mai S, Liu L Front Immunol. 2024; 15:1450927.

PMID: 39600698 PMC: 11588724. DOI: 10.3389/fimmu.2024.1450927.


Dietary therapies interlinking with gut microbes toward human health: Past, present, and future.

Chen J, Luo J, Pouwels S, Li B, Wu B, Abdelbaki T Imeta. 2024; 3(5):e230.

PMID: 39429878 PMC: 11487551. DOI: 10.1002/imt2.230.


Efficacy and Safety of a Low-FODMAP Diet in Combination with a Gluten-Free Diet for Adult Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.

Zhang J, Yu P, Xu Y, Lu X, Xu Y, Hang J Dig Dis Sci. 2024; 69(11):4124-4132.

PMID: 39407084 DOI: 10.1007/s10620-024-08671-8.


Dietary Effects on the Gut Phageome.

Howard A, Carroll-Portillo A, Alcock J, Lin H Int J Mol Sci. 2024; 25(16).

PMID: 39201374 PMC: 11354428. DOI: 10.3390/ijms25168690.


Unveiling the dynamics of gut microbial interactions: a review of dietary impact and precision nutrition in gastrointestinal health.

Shang Z, Pai L, Patil S Front Nutr. 2024; 11:1395664.

PMID: 38873568 PMC: 11169903. DOI: 10.3389/fnut.2024.1395664.


References
1.
Kwan P, Brodie M . Early identification of refractory epilepsy. N Engl J Med. 2000; 342(5):314-9. DOI: 10.1056/NEJM200002033420503. View

2.
Dieterich W, Esslinger B, Schuppan D . Pathomechanisms in celiac disease. Int Arch Allergy Immunol. 2003; 132(2):98-108. DOI: 10.1159/000073710. View

3.
Ciccocioppo R, Di Sabatino A, Bauer M, Della Riccia D, Bizzini F, Biagi F . Matrix metalloproteinase pattern in celiac duodenal mucosa. Lab Invest. 2004; 85(3):397-407. DOI: 10.1038/labinvest.3700225. View

4.
Madsen J, Linnet J, Rumessen J . Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci. 2006; 51(1):147-53. DOI: 10.1007/s10620-006-3100-8. View

5.
Longstreth G, Grant Thompson W, Chey W, Houghton L, Mearin F, Spiller R . Functional bowel disorders. Gastroenterology. 2006; 130(5):1480-91. DOI: 10.1053/j.gastro.2005.11.061. View